Levacetylleucine Side Effects
Medically reviewed by Drugs.com. Last updated on Nov 10, 2024.
Applies to levacetylleucine: oral granules for oral suspension.
Side effects include:
Most common adverse reactions (≥5%): abdominal pain, dysphagia, upper respiratory tract infections, vomiting.
For healthcare professionals
Applies to levacetylleucine: oral granule for reconstitution.
General adverse events
Most common adverse reactions with a frequency of 5% or greater were abdominal pain, dysphagia, upper respiratory tract infections, and vomiting.[Ref]
Dermatologic
Gastrointestinal
- Common (1% to 10%): Abdominal pain, dysphagia, vomiting[Ref]
Hematologic
- Frequency not reported: Thrombocytopenia[Ref]
Respiratory
- Very common (10% or more): Upper respiratory tract infection (17%)[Ref]
See also:
References
1. (2024) "Product Information. Aqneursa (levacetylleucine)." IntraBio Inc
Frequently asked questions
More about levacetylleucine
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Levacetylleucine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
